The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 283-293.e7 , February 2010

Decision support in surgical management of ischemic cardiomyopathy

Read at the Eighty-eighth Annual Meeting of The American Association for Thoracic Surgery, San Diego, Calif, May 10–14, 2008.

  • Dustin Y. Yoon, MS

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Nicholas G. Smedira, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
    • Corresponding Author InformationAddress for reprints: Nicholas G. Smedira, MD, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Ave/Mail Stop J4-1, Cleveland, OH 44195.
    • ,
  • Edward R. Nowicki, MD, MS

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Katherine J. Hoercher, RN

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Jeevanantham Rajeswaran, MSc

      Affiliations

    • Department of Quantitative Health Sciences, Research Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Eugene H. Blackstone, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
    • Department of Quantitative Health Sciences, Research Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Bruce W. Lytle, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio

Received 1 May 2008 ,Revised 20 July 2009 ,Accepted 14 August 2009.

References 

  1. Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr Opin Cardiol. 2008;23:249–253
  2. Boyle CA, Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol. 1990;131:160–168
  3. Newman TB, Brown AN. Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc. 1997;4:233–237
  4. Blackstone EH, Naftel DC, Turner ME. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986;81:615–624
  5. Blackstone EH. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg. 2001;122:430–439
  6. Breiman L. Bagging predictors. Machine Learning. 1996;24:123–140
  7. Drake C, Fisher L. Prognostic models and the propensity score. Int J Epidemiol. 1995;24:183–187
  8. Sergeant P, Blackstone E, Meyns B. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG.K.U. Leuven Coronary Surgery Program. Eur J Cardiothorac Surg. 1997;12:1–19
  9. Gerds TA, Schumacher M. Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J. 2006;48:1029–1040
  10. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110:e340–e437
  11. Tolis GA, Korkolis DP, Kopf GS, Elefteriades JA. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg. 2002;74:1476–1481
  12. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS, Gillinov AM, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191–2201
  13. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381–387
  14. Gorman RC, Gorman JH. Invited commentary: Tolis GA, Jr. Korkolis DP, Kopf GS, Elefteriades JA. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg. 2002;74:1481
  15. Velazquez EJ, Lee KL, O'Connor CM, Oh JK, Bonow RO, Pohost GM, et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg. 2007;134:1540–1547
  16. Maxey TS, Reece TB, Ellman PI, Butler PD, Kern JA, Tribble CG, et al. Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2004;127:428–434
  17. Kron IL, Lerman BB, Haines DE, Flanagan TL, DiMarco JP. Coronary artery bypass grafting in patients with ventricular fibrillation. Ann Thorac Surg. 1989;48:85–89
  18. Langenburg SE, Buchanan SA, Blackbourne LH, Scheri RP, Sinclair KN, Martinez J, et al. Predicting survival after coronary revascularization for ischemic cardiomyopathy. Ann Thorac Surg. 1995;60:1193–1197
  19. Pasquet A, Lauer MS, Williams MJ, Secknus MA, Lytle B, Marwick TH. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism. Eur Heart J. 2000;21:125–136
  20. Buckberg GD. Congestive heart failure: treat the disease, not the symptom—return to normalcy. J Thorac Cardiovasc Surg. 2001;121:628–637
  21. Ratcliffe MB, Guy TS. The effect of preoperative diastolic dysfunction on outcome after surgical ventricular remodeling. J Thorac Cardiovasc Surg. 2007;134:280–283
  22. Burkhoff D, Wechsler AS. Surgical ventricular remodeling: a balancing act on systolic and diastolic properties. J Thorac Cardiovasc Surg. 2006;132:459–463
  23. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705–1717
  24. Young JB. Heart failure's near dead and dying: reconsidering our heart transplant wait list scheme. J Am Coll Cardiol. 2007;50:1291–1293
  25. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990-2005. J Am Coll Cardiol. 2007;50:1282–1290
  26. Murphy KM, Topel RH. Measuring the gains from medical research: an economic approach. Chicago: University of Chicago Press; 2003;
  27. Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol. 2001;165:1562–1568
  28. Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956;63:81–97
  29. Kareev Y. Seven (indeed, plus or minus two) and the detection of correlations. Psychol Rev. 2000;107:397–402
  30. Wright P. The harassed decision maker: time pressures, distractions, and the use of evidence. J Appl Psychol. 1974;59:555–561
  31. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13
  32. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856–1865
  33. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433
  34. Lietz K, Long J, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497–505
  35. Reason J. Human error: models and management. BMJ. 2000;320:768–770
  36. Blackstone EH. Thinking beyond the risk factors. Eur J Cardiothorac Surg. 2006;29:645–652

 Disclosures: None.

 D. Y. Yoon is supported in part by the American Association for Thoracic Surgery Summer Intern Scholarship for Medical Students. E. H. Blackstone is supported in part by the Kenneth Gee and Paula Shaw, PhD, Chair in Heart Research.

PII: S0022-5223(09)01266-5

doi: 10.1016/j.jtcvs.2009.08.055

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 283-293.e7 , February 2010

Article Tools

* Image Usage & Resolution